Last reviewed · How we verify
NCT06893900: ASPIC
Assessing Shoulder Pathways Involving the Cuff
trial in Rotator Cuff Shoulder Syndrome and Allied Disorders in 160 participants. Not yet recruiting.
27 March 2027
Quick facts
| Lead sponsor | University Hospital, Grenoble |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 160 |
| Start date | 12 May 2025 |
| Primary completion | 27 March 2027 |
| Estimated completion | 27 March 2027 |
Conditions studied
- Rotator Cuff Shoulder Syndrome and Allied Disorders — all drugs for Rotator Cuff Shoulder Syndrome and Allied Disorders →
- Rotator Cuff Related Shoulder Pain — all drugs for Rotator Cuff Related Shoulder Pain →
Sponsor
University Hospital, Grenoble
Who can join
18 and older, any sex, with Rotator Cuff Shoulder Syndrome and Allied Disorders or Rotator Cuff Related Shoulder Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
New recommendations regarding care pathways for the management of shoulder pain syndromes have recently been published. We aim to analyze and compare the existing care pathways and identify the most appropriate approaches for different patient profiles. Our primary objective is to compare pain levels and shoulder function one year after your initial consultation with your general practitioner for this episode. We also seek to assess which healthcare professionals you consult for your shoulder management, the treatments you receive (e.g., analgesics), and any imaging studies you undergo (if prescribed). We will send you notifications to remind you of the survey completion schedule and provide the link to access the questionnaire. Participation in this study requires your commitment and adherence to the timeline, as missing data may compromise the analysis of results. Non-participation in the study will not affect your current medical care.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06893900
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Grenoble trials
Trials by the same sponsor.
- NCT07479225 — Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study · NA · not yet recruiting
- NCT07477613 — Implantable Brain-Computer Interface for Upper-Limb Recovery After Stroke · NA · not yet recruiting
- NCT07379372 — Bladder Overactivity and Post-Botulinum Toxin Telemonitoring · NA · not yet recruiting
- NCT07166991 — Anesthesia sTrategy foR Organ Procurement In braiN dEath · Phase 3 · recruiting
- NCT07367880 — The Monument Test : A New Tool for Assessing the Ability to Name and Identify Unique Entities. (TeDIMO) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06893900 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Grenoble
- Last refreshed: 30 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06893900.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing